Rosetta Genomics is a molecular diagnostics company that develops and commercializes a range of microRNA-based molecular diagnostic tests. ROSG’s product portfolio includes: miRview®lung,  miRview®squamos, miRview®meso and miRview®kidney. The company also has a collaboration agreement with the University of California, Davis, to develop and validate a microRNA profile for muscle-invasive bladder cancer. For more information visit the company’s Web site at: www.rosettagenomics.com

Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. For more information on Aegis Capital, visit www.aegiscapcorp.com.

Let us hear your thoughts below: